Answer
The safety of onasemnogene abeparvovec has not been established in patients receiving hepatotoxic medicines or using hepatotoxic substances, experience in these patients is limited, and no interaction studies have been performed.
Sources for this answer
- Zolgensma 2 x 10Exp13 vector genomes/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 17Document updated
Sources checked